Brent K Blackburn insider trades: Cv Therapeutics (CVTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brent reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 6, 2009 | CVTX | ↓ Sell | 1,500 | $15.50 | $23K | Direct | Feb 9, 2009 (3d) |
| Jan 7, 2009 | CVTX | ↓ Sell | 1,500 | $9.38 | $14K | Direct | Jan 7, 2009 (0d) |
| Nov 6, 2008 | CVTX | ↓ Sell | 2,000 | $10.49 | $21K | Direct | Nov 6, 2008 (0d) |
| Oct 14, 2008 | CVTX | ↓ Sell | 2,000 | $8.93 | $18K | Direct | Oct 15, 2008 (1d) |
| Sep 9, 2008 | CVTX | ↓ Sell | 1,289 | $11.50 | $15K | Direct | Sep 9, 2008 (0d) |
| Aug 13, 2008 | CVTX | ↓ Sell | 1,500 | $10.17 | $15K | Direct | Aug 13, 2008 (0d) |
| Jul 31, 2008 | CVTX | ↓ Sell | 12,500 | $9.50 | $119K | Direct | Aug 1, 2008 (1d) |
| Jul 8, 2008 | CVTX | ↓ Sell | 1,266 | $7.61 | $10K | Direct | Jul 9, 2008 (1d) |
| Jun 17, 2008 | CVTX | ↓ Sell | 839 | $7.93 | $7K | Direct | Jun 18, 2008 (1d) |
| Apr 25, 2008 | CVTX | ↓ Sell | 12,500 | $9.51 | $119K | Direct | Apr 29, 2008 (4d) |
| Jan 10, 2008 | CVTX | ↓ Sell | 10,000 | $9.50 | $95K | Direct | Jan 10, 2008 (0d) |
| Dec 11, 2007 | CVTX | ↓ Sell | 18,951 | $9.72 | $184K | Direct | Dec 12, 2007 (1d) |
| Aug 16, 2007 | CVTX | ↓ Sell | 10,000 | $10.09 | $101K | Direct | Aug 17, 2007 (1d) |
| Aug 29, 2005 | CVTX | ↓ Sell | 8,000 | $25.73 | $206K | Direct | Aug 31, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Brent K Blackburn's insider trades
Brent K Blackburn is SVP, Drug Discovery & Dev at Cv Therapeutics (CVTX). Since Aug 29, 2005, Brent has reported no open-market purchases and 14 sales worth $946K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (14 filings), shares withheld for taxes (11 filings), grants and awards (7 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CVTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.